Victory Square Technologies Revenue Surges 434% in First Half

The company’s net income reached $6.5 million for the six-month period ending June 30, a sharp turnaround from a $0.1 million loss in the first half of 2025. This financial momentum was mirrored in the second quarter, where revenue hit $28.0 million, up 421% year-over-year. As of mid-year, Victory Square maintains a cash position of $20.2 million and working capital of $34.5 million.

Chief Executive Officer Shafin Diamond Tejani attributed the growth to the company’s venture-building model, which focuses on identifying large-market opportunities and providing operational support to scale. Hydreight Technologies remains the primary driver of this performance, managing a U.S. network of over 3,000 nurses and 300 independent doctors. Beyond digital health, Victory Square is diversifying its portfolio, advancing Insu Therapeutics’ buccal drug-delivery platform and launching a $10 million venture fund under the Pawsible brand to target the pet-health market.